Beam Therapeutics Inc.BEAMNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-393.64M
↓ 134% below average
Average (7y)
$-168.54M
Historical baseline
Range
High:$-8.58M
Low:$-393.64M
CAGR
+72.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-393.64M | -167.9% |
| 2023 | $-146.95M | +54.7% |
| 2022 | $-324.33M | -41.0% |
| 2021 | $-230.06M | -79.7% |
| 2020 | $-128.03M | -78.7% |
| 2019 | $-71.65M | -58.9% |
| 2018 | $-45.09M | -425.3% |
| 2017 | $-8.58M | - |